A Review and Current Update on Sentinel Lymph Node Biopsy of Breast Cancer

Authors

  • Stacia Novia Marta Department of Surgery, Bali Mandara General Hospital, Denpasar, Indonesia
  • Nyoman Dwi Aussi Hary Mastika Department of Surgery, Bali Mandara General Hospital, Denpasar, Indonesia
  • Hendry Irawan Department of Surgery, Division of Surgical Oncology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Denpasar, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.4316

Keywords:

Biopsy of the sentinel lymph node, Breast Cancer

Abstract

Sentinel lymph node biopsy (SLNB) has become the standard staging technique in the surgical treatment of breast cancer, replacing the older method of dissecting lymph nodes of the axilla. Several advantages like lowering of the morbidities that accompany the technique and being less invasive have given rise to a promising effect on life aspects of patients suffering from this morbidity. The procedure has evolved over the last few decades, but further studies are still needed to make improvements. Several aspects of the evolution of SLNB, such as the incorporation of the management in early cancer, the technique of lymphatic mapping, the accuracy of the technique, and its utility and evaluation in clinical response after neoadjuvant chemotherapy are discussed in this review.

 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

American Cancer Society. Cancer Facts and Figures 2018. Atlanta: American Cancer Society; 2018.

Leong SP, Shen ZZ, Liu TJ, Agarwai G, Tajima T, Paik NS, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308-24. https://doi. org/10.1007/s00268-010-0683-1 PMid:20607258

Faries MB, Bedrosian I, Reynolds C, Nguyen HQ, Alavi A, Czerniecki BJ. Active macromolecule uptake by lymph node antigen-presenting cells: A novel mechanism in determining sentinel lymph node status. Ann Surg Oncol. 2000;7(2):98-105. https://doi.org/10.1007/s10434-000-0098-6 PMid:10761787

Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med. 1977;297(12):627-30. https://doi.org/10.1056/nejm197709222971202 PMid:895764

Krag DN, Weavert DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2(6):335-9. https://doi. org/10.1016/0960-7404(93)90064-6 PMid:8130940

Turkbey B, Ravizzini G, Choyke PL, Kobayashi H. Lymphangiogenesis and imaging of the lymphatics in cancer. In: Stacker SA, Achen MG, editors. Lymphangiogenesis in Cancer Metastasis Cancer Metastasis-biology and Treatment. Vol. 13. Switzerland: Springer; 2012. p.159-84. https://doi. org/10.1007/978-90-481-2247-9_7

Giuliano AE, Ballman KV, Mccall L, Beitsch PD, Brennan MB, Kelemen PR, et al. Effect of axillary dissection VS no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA. 2017;318(10):918-26. https://doi.org/10.1001/jama.2017.11470 PMid:28898379

Kreienberg R, Albert US, Folimann M, Kopp IB, Kuhn T, Wockel A. Interdisciplinary GoR level III guidelines for the diagnosis, treatment, and follow-up care of breast cancer. Geburtshilfe Frauenheilkd. 2013;73(6):556-83. https://doi. org/10.1055/s-0032-1328689 PMid:24771925

Ban EJ, Lee JS, Koo JS, Park S, Kim S I, Park B. Breast cancer how many sentinel lymph nodes are enough for accurate axillary staging in T1-2 breast cancer? J Breast Cancer. 2011;14(4):296- 300. https://doi.org/10.4048/jbc.2011.14.4.296 PMid:22323916

Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a sentinel node in cancer of the parotid. Cancer. 1960;13:77-8. https://doi.org/10.1002/1097-0142(196001/02)13:1<77:aid-cncr2820130114>3.0.co;2-d PMid:13828575

Wespes E, Simon J, Schulman C. Cabanas approach: Is sentinel lymph node biopsy reliable for staging penile carcinoma? Urology. 1986;28(4):278-9. https://doi. org/10.1016/0090-4295(86)90004-x PMid:3765235

Cochran AJ, Wen D, Morton DL, Cochran AJ, Angeles L. Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg. 1992;16(2):214-21. https://doi.org/10.1007/bf02071523 PMid:1561801

Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for reast cancer. Ann Surg. 1994;220(3):391-8. https://doi. org/10.1097/00000658-199409000-00015 PMid:8092905

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927-33. https://doi.org/10.1016/ s1470-2045(10)70207-2 PMid:20863759

James TA, Coffman AR, Chagpar AB, Frcs C, Boughey JC, Klimberg VS, et al. Troubleshooting sentinel lymph node biopsy in breast cancer surgery. Ann Surg Oncol. 2016;23(11):3459-66. https://doi.org/10.1245/s10434-016-5432-8 PMid:27444110

Bonneau C, Bendifallah S, Reyal F, Rossi L, Rouzier R. Association of the number of sentinel lymph nodes harvested with survival in breast cancer. Eur J Surg Oncol. 2015;41(1):52-8. https://doi.org/10.1016/j.ejso.2014.11.004 PMid:25466979

Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, et al. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques. Surgery. 1999;126(4):714-20. https://doi.org/10.1016/ s0039-6060(99)70127-3 PMid:10520920

Stein RG, Fricker R, Rink T, Fitz H, Blasius S, Diessner J, et al. Evaluation of sentinel lymph node biopsy and axillary lymph node dissection for breast cancer treatment concepts-a retrospective study of 1,214 breast cancer patients. Breast Care (Basel). 2017;12(5):324-8. https://doi.org/10.1159/000477610 PMid:29234253

Pitsinis V, Provenzano E, Kaklamanis L, Wishart GC, Benson JR. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer. Surg Oncol. 2015;24(4):375-9. https://doi.org/10.1016/j.suronc.2015.10.002 PMid:26555151

Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T. Evaluation of sentinel node biopsy by combined fluorescence and dye method and lymph flow for breast cancer. Breast. 2010;19(3):210-3. https://doi.org/10.1016/j.breast.2010.01.014 PMid:20153649

Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph node in early-stage breast cancer. Ann Surg Oncol. 2013;20(7):2213-8. https://doi.org/10.1245/s10434-013-2890-0 PMid:23429938

Van der Vorst JR, Schaafsma BE, Verbeek FP, Hutteman M, Mieog JS, Lowik CW, et al. Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol. 2012;19(13):4104-11. https://doi.org/10.1245/ s10434-012-2466-4 PMid:22752379

Nielsen MA, Bull J, Culpan AM, Munyombwe T, Sharma N, Whitaker M, et al. Preoperative sentinel lymph node identification, biopsy and localisation using contrast enhanced ultrasound (CEUS) in patients with breast cancer: A systematic review and meta-analysis. Clin Radiol. 2017;72(11):959-71. https://doi.org/10.1016/j.crad.2017.06.121 PMid:28774472

Colleoni M, Viale G, Zahrieh D, Pruneri G, Gentilini O, Veronesi P, et al. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: A study of preoperative treatment. Clin Cancer Res. 2004;10(19):6622-8. https://doi.org/10.1158/1078-0432.ccr-04-0380 PMid:15475452

van Deurzen CH, Vriens BP, Tjan-Heijnen VC, van der Wall E, Albregts M, van Hilligersberg R, et al. Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review. Eur J Cancer. 2009;45(18):3124-30. https://doi.org/10.1016/j.ejca.2009.08.001 PMid:19716287

Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): A prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609-18. https:// doi.org/10.1016/s1470-2045(13)70166-9 PMid:23683750

Enokido K, Watanabe C, Nakamura S, Ogiya A, Osako T, Akiyama F, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with an initial diagnosis of cytology-proven lymph node-positive breast cancer. Clin Breast Cancer. 2016;16(4):299-304. https://doi.org/10.1016/j.clbc.2016.02.009 PMid:26993216

Classe JM, Bordes V, Campion L, Mignotte H, Dravet F, Leveque J, et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: Results of ganglion sentinelle et chimiotherapie neoadjuvante, a french prospective multicentric study. J Clin Oncol. 2009;27(5):726-32. https://doi. org/10.1200/jco.2008.18.3228 PMid:19114697

Downloads

Published

2020-03-23

How to Cite

1.
Marta SN, Hary Mastika NDA, Irawan H. A Review and Current Update on Sentinel Lymph Node Biopsy of Breast Cancer. Open Access Maced J Med Sci [Internet]. 2020 Mar. 23 [cited 2024 Apr. 26];8(F):78-83. Available from: https://oamjms.eu/index.php/mjms/article/view/4316

Issue

Section

Systematic Review Article

Categories